Postmarket Implant Studies, Registries Urged In Senate Funding Report
This article was originally published in The Gray Sheet
Executive Summary
The Senate Appropriations Committee is asking FDA to track implanted devices more carefully after they are approved for market, using patient registries, post-market surveillance and long-term Phase IV trials